AhmadShabsighMD, MBA(He/Him)

Minimally Invasive Surgery, Surgical Oncology

Medical Director of Enhanced Surgical Recovery Associate medical director of perioperative quality and safety. OSU Comprehensive Cancer Center Vice chair for quality. Department of Urology, Ohio State University College of Medicine

Join to view full profile

Dr. Shabsigh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Shabsigh's full profile

Already have an account?

Office
2121 Kenney road
Columbus, OH 43212
Phone+1 614-685-4263

Fax+1 614-685-4768

Education & Training

New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 2001 - 2008
New York Presbyterian HospitalInternship, Transitional Year, 2000 - 2001
University of Aleppo Faculty of MedicineClass of 1995

Certifications & Licensure

OH State Medical License 2008 - 2026
NY State Medical License 2005 - 2012
American Board of Urology Urology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Fellow (FACS) American College of Surgeons

Clinical Trials

Biomarker Identification for Bladder Cancer Patients Start of enrollment: 2014 Jan 21
Active, not recruiting
Blue Light Cystoscopy With Cysview® Registry Start of enrollment: 2014 Apr 01
Recruiting
Postoperative Delirium in Patients Undergoing Radical Cystectomy Start of enrollment: 2018 Jan 10
Completed
Not Applicable

Publications & Presentations

PubMed

Long-Term Outcomes of Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma With UGN-101, a Mitomycin Reverse Thermal Gel.
Phillip M Pierorazio, Nir Kleinmann, Ahmad Shabsigh, Brian Hu, Jay D Raman
The Journal of Urology. 2025-03-01
Patient-Derived Conditionally Reprogrammed Cells in Prostate Cancer Research.
Abdalla Elbialy, Deepthi Kappala, Dhruv Desai, Peng Wang, Ahmed Fadiel
Cells. 2024-06-08
38 citations
NCCN Guidelines® Insights: Prostate Cancer, Version 3.2024.
Edward M Schaeffer, Sandy Srinivas, Nabil Adra, Yi An, Rhonda Bitting
Journal of the National Comprehensive Cancer Network. 2024-04-01

Journal Articles

Multi-Institutional Experience with Robotic Nephrectomy with Inferior Vena Cava Tumor Thrombectomy
Mani Menon, Ahmad Shabsigh, Daniel Eun, Craig Rogers, Monish Aron, Erik Castle, Mohamad Allaf, Chandru P Sundaram, Ronney Abaza, Jim C Hu, The Journal of Urology

Press Mentions

PSA Density plus MRI May Improve Detection of Clinically Significant Prostate CancerJuly 7th, 2020
Advanced Prostate Cancers Still Rising in U.S.May 20th, 2020
Prostate Cancer Detection Greater with Targeted plus Systematic BiopsyJune 14th, 2019
Join now to see all